Early revascularization of fat grafts conducted by basic fibroblast growth factor sustained-release system

doi:10.3969/j.issn.2095-4344.2013.44.015

Abstract

Abstract:

BACKGROUND: The resorption and unprediction of fat transplantation directly influence the clinical application. The technology of reducing graft resorption by using various cytokines to promote early revascularization of fat transplantation needs to be improved. But the effect is not stable, as the cytokines losing with the bleeding and exudation thus cannot long-term affect the vascular endothelial cells.
OBJECTIVE: To investigate the effect of alkaline recombinant basic fibroblast growth factor-dextran formed sustained-release system on the early revascularization of fat grafts.
METHODS: The recombinant basic fibroblast growth factor solution 2 mg/L and basic fibroblast growth factor-dextran sustained-release granules were prepared. The fat tissues were selected from the inguinal region of 12 Sprague-Dawley rats for fat transplantation. The left backs of the rats were treated with subcutaneously injection of fat pearl plus recombinant basic fibroblast growth factor solution (control group), and the right backs of rats were treated with subcutaneously injection of fat pearl plus basic fibroblast growth factor-dextran sustained-release granules (sustained-release system group). At 7 and 14 days after treatment, one rat in each group was sacrificed randomly, then ink perfusion microvascular imaging was used to observe the inside of the graft and the density of early formed coated vessels. At 90 days after transplantation, the rest rats were sacrificed, and the grafts were obtained to measure the volume.
RESULTS AND CONCLUSION: At 7 and 14 days after transplantation, the number of vessels in the capsule and grafts of the sustained-release system group was higher than that in the control group (P < 0.01). At 90 days after transplantation, the volume of grafts in the sustained-release system groups was bigger than that in the control group (P < 0.05). The recombinant basic fibroblast growth factor-dextran delivery system could better promote the early revascularization of fat grafts. The experimental results suggest that recombinant basic fibroblast growth factor-dextran sustained-release system can help to reduce the absorption of fat grafts after surgery.

Key words: organ transplantation, tissue transplantation, subcutaneous fat, adipose tissue, fibroblast growth factors

CLC Number:

R318

Jin Yuan-rong, Yang Se-fei. Early revascularization of fat grafts conducted by basic fibroblast growth factor sustained-release system[J]. Chinese Journal of Tissue Engineering Research, 2013, 17(44): 7745-7750.

Figures/Tables 3

References

[1]Locke MB, de Chalain TM. Current practice in autologous fat transplantation: suggested clinical guidelines based on a review of recent literature. Ann Plast Surg. 2008;60(1):98-102.
[2]Sommer B, sattler G. Current concepts of fat graft survival: histology of aspirated adipose tissue and review of the literature.Dermatol Surg.2000;26(12):1159-1166.
[3]Buchy LP, Percec I.The science of autologous fat grafting: views on current and future approaches to neoadipogenesis. Anethet Surg J.2008;28(3):313-321.
[4]Kaufman MR, Miller TA, Huang C. et al. Autologous fat transfer for facial recontouring: is there science behind the art? Plast Reconstr Surg.2007;119(7):2287-2296.
[5]Nguyen PS, Desouches C, Gay AM, et al. Development of micro-injection as an innovative autologous fat graft technique: The use of adipose tissue as dermal filler. J Plast Reconstr Aesthet Surg. 2012;65(12):1692-1699.
[6]Alghoul M, Mendiola A, Seth R.et al. The effect of hyaluronan hydrogel on fat graft survival. Aethet Surg J. 2012;1;32(5): 622-633.
[7]Metzinger S, Parrish J, Guerra A, et al. Autologous fat grafting to the lower one-third of the face. Facial Plast Surg.2012; 28(1): 21-33.
[8]Wetterau M, Szpalski C, Hazen A, et al. Autologous fat grafting and facial reconstruction. J Craniofac Surg. 2012;23(1):315-318.
[9]Booth BW, Yang CC, Burg KJ. Assessment of a Chitosan/Hyaluronan Injectable Composite for Fat Reconstruction. J Biomater Sci Polym Ed. 2012 Jan 12.
[10]Tabit CJ, Slack GC, Fan K, et al.Fat grafting versus adipose- derived stem cell therapy: distinguishing indications, techniques, and outcome. Aesthetic Plast Surg.2012;36(3):704-713.
[11]毋巨龙,李世荣.bFGF对颗粒脂肪移植成活率的影响及CT影像学研究[J].重庆医学,2008,37(12):1314-1315.
[12]韩焱福,刘军. bFGF辅助自体脂肪颗粒注射治疗面部凹陷[J].中国修复重建外科杂志.2008,22(3):339-342.
[13]毋巨龙,李世荣.bFGF对前脂肪细胞增殖和分化的作用[J].中国美容医学,2007,16(10):1350-1352.
[14]彭智,贾振华,刘晓韬. 微渗透泵持续恒量灌注血管内皮细胞生长因子对大鼠脂肪移植体成活率的影响[J].中国组织工程研究与临床康复,2009,13(31):6063-606.
[15]Dong Z, Fu R, Liu L, et al. Stromal vascular fraction (SVF) cells enhance long-term survival of autologous fat grafting through the facilitation of M2 macrophages. Cell Biol Int. 2013 Mar 22.
[16]Liu B, Tan XY, Liu YP, et al. The adjuvant use of stromal vascular fraction and platelet-rich fibrin for autologous adipose tissue transplantation. Tissue Eng Part C Methods. 2013 ;19(1):1-14.
[17]Gentile P, Orlandi A, Scioli MG, et al. A comparative translational study: the combined use of enhanced stromal vascular fraction and platelet-rich plasma improves fat grafting maintenance in breast reconstruction. Stem Cells Transl Med. 2012 ;1(4):341-351.
[18]Li J, Gao J, Cha P, et al. Supplementing fat grafts with adipose stromal cells for cosmetic facial contouring. Dermatol Surg. 2013;39(3 Pt 1):449-456.
[19]Li K, Gao J, Zhang Z, et al. Selection of donor site for fat grafting and cell isolation. Aesthetic Plast Surg. 2013;37(1): 153-158.
[20]Lee SK, Kim DW, Dhong ES, et al. Facial Soft Tissue Augmentation using Autologous Fat Mixed with Stromal Vascular Fraction. Arch Plast Surg. 2012 ;39(5):534-549.
[21]Yuan Y, Gao J, Liu L, et al. Role of adipose-derived stem cells in enhancing angiogenesis early after aspirated fat transplantation: induction or differentiation? Cell Biol Int. 2013 Feb 13.
[22]Lequeux C, Oni G, Wong C, et al. Subcutaneous fat tissue engineering using autologous adipose-derived stem cells seeded onto a collagen scaffold. Plast Reconstr Surg. 2012; 130(6):1208-1217.
[23]Cohen SR, Mailey B. Adipocyte-derived stem and regenerative cells in facial rejuvenation. Clin Plast Surg. 2012 ;39(4):453-464.
[24]Hsu VM, Stransky CA, Bucky LP, et al. Fat grafting's past, present, and future: why adipose tissue is emerging as a critical link to the advancement of regenerative medicine. Aesthet Surg J. 2012 ;32(7):892-899.
[25]Gir P, Oni G, Brown SA, et al.Human adipose stem cells: current clinical applications. Plast Reconstr Surg. 2012; 129(6):1277-1290.
[26]Tabit CJ, Slack GC, Fan K, et al. Fat grafting versus adipose-derived stem cell therapy: distinguishing indications, techniques, and outcomes. Aesthetic Plast Surg. 2012 ;36(3): 704-713.
[27]Chang L, Wang J, Zheng D, et al. Improvement of the Survival of Autologous Free-Fat Transplants in Rats Using Vascular Endothelial Growth Factor 165-Transfected Bone Mesenchymal Stem Cells. Ann Plast Surg. 2013 Mar 28.
[28]Trojahn Kølle SF, Oliveri RS, Glovinski PV, et al. Importance of mesenchymal stem cells in autologous fat grafting: a systematic review of existing studies. J Plast Surg Hand Surg. 2012;46(2):59-68.
[29]Li SL, Liu Y, Hui L. Construction of engineering adipose-like tissue in vivo utilizing human insulin gene-modified umbilical cord mesenchymal stromal cells with silk fibroin 3D scaffolds. J Tissue Eng Regen Med. 2013 Mar 19.
[30]Chung CW, Marra KG, Li H, et al. EGF microsphere technology to enhance vascularization in fat grafting.Ann Plast Surg. 2012;69(2):213-219.
[31]梁爽,袁桂峰,钟毓娟,等.小鼠脂肪干细胞的免疫原性及移植安全性[J].中国组织工程研究与临床康复, 2012,16(1):47-50.
[32]岳毅刚,全媛,邵家松,等.不同浓度血管内皮细胞生长因子皮下局部注射对大鼠脂肪移植体存活率的影响[J].华夏医学,2011, 24(6): 643-648.
[33]邓颖,曾令寰,李伟,等.胰岛素促进大鼠移植脂肪微血管的形成[J]. 中国组织工程研究,2013,17(18):3318-3324.
[34]Sultan SM,Butala P,Barr JS, et al.热损伤后脂肪移植促进新生血管形成并降低纤维变性[J].中国美容整形外科杂志,2011, 22(9): 10022-10022.
[35]麦凯欣,朱辉,崔永言. SVF-PLGA联合脂肪移植体内构建组织工程化软组织充填材料的初步研究[J].组织工程与重建外科,2010, 6(1):9-13.
[36]杜学亮,罗少军,郝新光,等.碱性成纤维细胞生长因子在颗粒脂肪移植后血运重建过程的作用[J].中华整形外科杂志,2005,21(2): 128-131.
[37]王巍巍,王葳,程劲,等.低氧诱导因子1α基因修饰脂肪干细胞修复小鼠急性肾损伤[J].中国组织工程研究, 2012,16(41): 7651-7657.
[38]蒋爱梅,王艳梅,董毅龙,等. 脂肪干细胞结合碱性成纤维细胞生长因子辅助颗粒脂肪移植的实验研究[J]. 昆明医科大学学报, 2013,34(4):8-12.
[39]Sykes JM, Tapias V, Pu LL. Autologous fat grafting viability: lower third of the face. Facial Plast Surg. 2010;26(5):376-384.
[40]Lam SM, Glasgold RA, Glasgold MJ. Fat harvesting techniques for facial fat transfer. Facial Plast Surg. 2010;26(5): 356-361.
[41]郭万里,张宝林. 肝细胞生长因子(HGF)对脂肪移植存活的影响[J].中国现代药物应用,2009,3(10):32-33.
[42]殷剑,杨毅,杨小丰,等.快速浓集自体脂肪干细胞促进移植异体骨早期血管化[J].中国组织工程研究, 2012,16(27):4996-5000.